FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1492175909> ?p ?o ?g. }

• W1492175909 endingPage "1406" @default.
• W1492175909 startingPage "1396" @default.
• W1492175909 abstract "Background: The withdrawal of certain cyclooxygenase-2 selective drugs and the availability of over-the-counter non-steroidal anti-inflammatory drugs (NSAIDs) have increased the pressure for researching and prescribing conventional NSAIDs with a favourable efficacy/tolerance ratio in inflammatory diseases, particularly rheumatoid arthritis. The aim of this comprehensive meta-analysis was to evaluate the absolute and relative efficacy and safety of flurbiprofen in the management of rheumatoid arthritis. Methods: A systematic and exhaustive bibliographic research of published literature has been performed. The inclusion criteria are summarised as follows: randomised trial and rheumatoid arthritis and flurbiprofen and oral administration and anti-inflammatory doses from 100 to 300 mg and (placebo or aspirin or indomethacin or naproxen or ibuprofen or ketoprofen) and (articular pain or stiffness or swelling or mobility or patient/physician reported efficacy or tolerance or gastrointestinal (GI) tolerance). Studies were conducted from January 1975 to January 2006. Analyses have been stratified by comparisons and outcomes. Publication bias and robustness have been extensively investigated. Results: Fourteen studies, accounting for 1103 patient-years, have been included in the quantitative review. The mean daily doses administrated were 200 mg flurbiprofen, 4000 mg aspirin, 150 indomethacin, 750 mg naproxen and 1800 mg ibuprofen. Flurbiprofen was superior to placebo for all outcomes, and superior to three of four other NSAIDs in terms of formal symptomatic measures (pain, stiffness and swelling). Several patients or physicians reported the efficacy of flurbiprofen as superior to indomethacin and naproxen, while its safety, and particularly its GI tolerance were better compared with aspirin and indomethacin. Sensitivity analyses have reported a sufficient robustness against systematic publication bias assumptions. Conclusion: This meta-analysis has shown that flurbiprofen is an interesting alternative to commonly prescribed NSAIDs in the symptomatic management of rheumatoid arthritis, especially given its favourable efficacy/tolerance ratio." @default.
• W1492175909 created "2016-06-24" @default.
• W1492175909 creator A5011021251 @default.
• W1492175909 creator A5020215683 @default.
• W1492175909 creator A5028436742 @default.
• W1492175909 creator A5028502093 @default.
• W1492175909 date "2007-06-26" @default.
• W1492175909 modified "2023-09-29" @default.
• W1492175909 title "Flurbiprofen in the symptomatic management of rheumatoid arthritis: a valuable alternative" @default.
• W1492175909 cites W1964596810 @default.
• W1492175909 cites W1971818135 @default.
• W1492175909 cites W1975770782 @default.
• W1492175909 cites W1980520425 @default.
• W1492175909 cites W1982973447 @default.
• W1492175909 cites W1984645623 @default.
• W1492175909 cites W1999580315 @default.
• W1492175909 cites W2003185617 @default.
• W1492175909 cites W2007129901 @default.
• W1492175909 cites W2022525420 @default.
• W1492175909 cites W2023633252 @default.
• W1492175909 cites W2028306873 @default.
• W1492175909 cites W2033585778 @default.
• W1492175909 cites W2033603763 @default.
• W1492175909 cites W2038410983 @default.
• W1492175909 cites W204046373 @default.
• W1492175909 cites W2048152958 @default.
• W1492175909 cites W2049002895 @default.
• W1492175909 cites W2054322253 @default.
• W1492175909 cites W2057806510 @default.
• W1492175909 cites W2062319882 @default.
• W1492175909 cites W2083101681 @default.
• W1492175909 cites W2090748623 @default.
• W1492175909 cites W2112203054 @default.
• W1492175909 cites W2114935368 @default.
• W1492175909 cites W2123012605 @default.
• W1492175909 cites W2129208878 @default.
• W1492175909 cites W2129535650 @default.
• W1492175909 cites W2146136250 @default.
• W1492175909 cites W2152574589 @default.
• W1492175909 cites W2156416679 @default.
• W1492175909 cites W2157347940 @default.
• W1492175909 cites W2157823046 @default.
• W1492175909 cites W2162828250 @default.
• W1492175909 cites W2168077861 @default.
• W1492175909 cites W2188185440 @default.
• W1492175909 cites W2322177620 @default.
• W1492175909 cites W2330496155 @default.
• W1492175909 cites W25232284 @default.
• W1492175909 doi "https://doi.org/10.1111/j.1742-1241.2007.01452.x" @default.
• W1492175909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17596188" @default.
• W1492175909 hasPublicationYear "2007" @default.
• W1492175909 type Work @default.
• W1492175909 sameAs 1492175909 @default.
• W1492175909 citedByCount "30" @default.
• W1492175909 countsByYear W14921759092012 @default.
• W1492175909 countsByYear W14921759092013 @default.
• W1492175909 countsByYear W14921759092014 @default.
• W1492175909 countsByYear W14921759092015 @default.
• W1492175909 countsByYear W14921759092016 @default.
• W1492175909 countsByYear W14921759092017 @default.
• W1492175909 countsByYear W14921759092018 @default.
• W1492175909 countsByYear W14921759092019 @default.
• W1492175909 countsByYear W14921759092020 @default.
• W1492175909 countsByYear W14921759092022 @default.
• W1492175909 countsByYear W14921759092023 @default.
• W1492175909 crossrefType "journal-article" @default.
• W1492175909 hasAuthorship W1492175909A5011021251 @default.
• W1492175909 hasAuthorship W1492175909A5020215683 @default.
• W1492175909 hasAuthorship W1492175909A5028436742 @default.
• W1492175909 hasAuthorship W1492175909A5028502093 @default.
• W1492175909 hasBestOaLocation W14921759091 @default.
• W1492175909 hasConcept C126322002 @default.
• W1492175909 hasConcept C141071460 @default.
• W1492175909 hasConcept C142724271 @default.
• W1492175909 hasConcept C204787440 @default.
• W1492175909 hasConcept C27081682 @default.
• W1492175909 hasConcept C2776164576 @default.
• W1492175909 hasConcept C2777077863 @default.
• W1492175909 hasConcept C2777575956 @default.
• W1492175909 hasConcept C2777628954 @default.
• W1492175909 hasConcept C2778115740 @default.
• W1492175909 hasConcept C2779944601 @default.
• W1492175909 hasConcept C2780744026 @default.
• W1492175909 hasConcept C2780820201 @default.
• W1492175909 hasConcept C2781000538 @default.
• W1492175909 hasConcept C42219234 @default.
• W1492175909 hasConcept C71924100 @default.
• W1492175909 hasConcept C98274493 @default.
• W1492175909 hasConceptScore W1492175909C126322002 @default.
• W1492175909 hasConceptScore W1492175909C141071460 @default.
• W1492175909 hasConceptScore W1492175909C142724271 @default.
• W1492175909 hasConceptScore W1492175909C204787440 @default.
• W1492175909 hasConceptScore W1492175909C27081682 @default.
• W1492175909 hasConceptScore W1492175909C2776164576 @default.
• W1492175909 hasConceptScore W1492175909C2777077863 @default.
• W1492175909 hasConceptScore W1492175909C2777575956 @default.
• W1492175909 hasConceptScore W1492175909C2777628954 @default.
• W1492175909 hasConceptScore W1492175909C2778115740 @default.

• next